Where AI startups unlock $25M ARR: the mid‑funnel advantage
What Changed and Why It Matters ICONIQ’s latest B2B SaaS readout puts a spotlight on where growth actually breaks loose. Mid-stage companies in the $25M–$100M ARR band are finally pushing…
What VCs want before funding your AI startup in 2025
What Changed and Why It Matters Generative AI rewired venture calculus. Startups can ship more with fewer people and less cash. But the bar for proof is higher. “Virtually all…
Why AI drug startups are raising big as FDA tests faster reviews
What Changed and Why It Matters The U.S. FDA is piloting generative AI to support its drug review workflow. The agency’s goal: faster document triage, smarter search across prior decisions,…